Sort
261,768 grants matching “gene therapy”
The Cancer Target Discovery and Development Network at UCSF
$1,029,182Michael T McManus · University Of California, San Francisco · U01 · FY2020 · CA
Cancer Metabolism and Growth
$1,029,093Wei-Xing Zong · Rbhs -Cancer Institute Of New Jersey · P30 · FY2022 · CA
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$1,028,940Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Perivascular plasticity in metastatic microenvironments
$1,028,925Meera Murgai · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Biomarker Signatures of TB Infection in Young Children With and Without HIV
$1,028,909Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis
$1,028,903Christiane S Hampe · Immusoft Corporation · R44 · FY2018 · GM
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,028,860Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform
$1,028,842Lyndsey Linke · Sivec Biotechnologies, Llc · R44 · FY2020 · AI
Determining the Fate of Transmembrane Proteins
$1,028,830Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,028,782Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,028,782Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Studies in pig-to-primate cardiac xenotransplantation
$1,028,749Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2014 · AI
Biomedical and Health Informatics Training Program
$1,028,664Peter Tarczy-Hornoch · University Of Washington · T15 · FY2007 · LM
Molecular Atlas of Lung Development - Data Coordinating Center
$1,028,639Scott M Palmer · Duke University · U01 · FY2014 · HL
Non-oncogene addiction in cancer cells
$1,028,502Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
$1,028,501Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
INDâenabling development of MMâ008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring
$1,028,445Richard A Cone · Mucommune, Llc · R44 · FY2023 · HD
Clinical Pharmacogenetics
$1,028,401William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
$1,028,400Neal Rosen · Sloan-Kettering Inst Can Research · R35 · FY2017 · CA
Isolation, characterization and translational development of glioma stem cells
$1,028,400Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2018 · CA
Isolation, characterization and translational development of glioma stem cells
$1,028,400Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2017 · CA
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
$1,028,400Neal Rosen · Sloan-Kettering Inst Can Research · R35 · FY2016 · CA
Engineered HSV for Treatment of Malignant Gliomas
$1,028,381University Of Alabama At Birmingham · P01 · FY2003 · CA
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation
$1,028,348Sanford D Markowitz · Case Western Reserve University · U01 · FY2023 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$1,028,281Francis Flomerfelt · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA